BG61690B1 - (s)(+)-2-етокси-4-/n-/i-(2-пиперидино-фенил)-3-метил-i-бутил/аминокарбонилметил/-бензоена киселина - Google Patents

(s)(+)-2-етокси-4-/n-/i-(2-пиперидино-фенил)-3-метил-i-бутил/аминокарбонилметил/-бензоена киселина Download PDF

Info

Publication number
BG61690B1
BG61690B1 BG98300A BG9830093A BG61690B1 BG 61690 B1 BG61690 B1 BG 61690B1 BG 98300 A BG98300 A BG 98300A BG 9830093 A BG9830093 A BG 9830093A BG 61690 B1 BG61690 B1 BG 61690B1
Authority
BG
Bulgaria
Prior art keywords
group
compound
phenyl
general formula
methyl
Prior art date
Application number
BG98300A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98300A (bg
Inventor
Wolfgang Grell
Andreas Greischel
Gabriele Zahn
Michael Mark
Hansjoerg Knorr
Eckhard Rupprecht
Uelrich Mueller
Original Assignee
Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36781542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG61690(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thomae Gmbh filed Critical Thomae Gmbh
Publication of BG98300A publication Critical patent/BG98300A/bg
Publication of BG61690B1 publication Critical patent/BG61690B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG98300A 1991-06-21 1993-12-14 (s)(+)-2-етокси-4-/n-/i-(2-пиперидино-фенил)-3-метил-i-бутил/аминокарбонилметил/-бензоена киселина BG61690B1 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
PCT/EP1991/001147 WO1993000337A1 (de) 1991-06-21 1991-06-21 (s)(+)-2-äthoxy-4-[n-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]-benzoesäure
CA002111851A CA2111851C (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
CN91104984A CN1048722C (zh) 1991-06-21 1991-07-22 (s)(+)-2-乙氧基-4-[n-[1-(2-哌啶子基-苯基)-3-甲基-1-丁基]氨基羰基甲基]苯甲酸,含该化合物的药物组合物及其制备方法

Publications (2)

Publication Number Publication Date
BG98300A BG98300A (bg) 1994-09-30
BG61690B1 true BG61690B1 (bg) 1998-03-31

Family

ID=36781542

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98300A BG61690B1 (bg) 1991-06-21 1993-12-14 (s)(+)-2-етокси-4-/n-/i-(2-пиперидино-фенил)-3-метил-i-бутил/аминокарбонилметил/-бензоена киселина

Country Status (18)

Country Link
EP (1) EP0589874B1 (da)
JP (1) JP2921982B2 (da)
KR (1) KR100496720B1 (da)
CN (1) CN1048722C (da)
AU (1) AU660930B2 (da)
BG (1) BG61690B1 (da)
CA (1) CA2111851C (da)
DE (2) DE59109151D1 (da)
DK (2) DK0589874T3 (da)
FI (1) FI106027B (da)
GR (1) GR3031654T3 (da)
NO (2) NO303687B1 (da)
PL (1) PL170210B1 (da)
RO (1) RO113462B1 (da)
SG (1) SG43036A1 (da)
SK (1) SK281246B6 (da)
UY (1) UY25923A1 (da)
WO (1) WO1993000337A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201139T1 (de) 1997-06-13 2001-06-15 Novo Nordisk As Neue dosierung für diabetes type 2
IN192862B (da) 1999-11-16 2004-05-22 Ranbaxy Lab Ltd
PE20020617A1 (es) 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040102477A1 (en) * 2002-08-23 2004-05-27 Dr. Reddy's Laboratories Limited Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof
WO2004101540A2 (de) * 2003-05-14 2004-11-25 Cilag Ag Verfahren zur herstellung von phenylessigsäurederivaten
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005021524A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of repaglinide
CN1305863C (zh) * 2004-12-27 2007-03-21 浙江大学 (s)－异丙基－(2－哌啶)苯基－甲基胺的合成方法
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
FR2898894B1 (fr) * 2006-03-24 2008-06-06 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
US7893080B2 (en) * 2006-10-20 2011-02-22 Neurendo Pharma, Llc Method of restoring the incretin effect
US8101769B2 (en) 2007-02-15 2012-01-24 Actavis Group Ptc Ehf Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide
WO2009004485A2 (en) * 2007-06-06 2009-01-08 Actavis Group Ptc Ehf Repaglinide substantially free of dimer impurity
EP2019097A1 (en) 2007-07-25 2009-01-28 Aurobindo Pharma Limited Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine
DK2200588T3 (da) 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
DE102008046995B4 (de) * 2008-09-12 2010-08-26 Stada Arzneimittel Ag 2-Ethoxy-benzoesäurederivat
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
US8455522B2 (en) 2009-05-15 2013-06-04 Novartis Ag Benzoxazolone derivatives as aldosterone synthase inhibitors
NZ596302A (en) 2009-05-15 2014-01-31 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
JP5466759B2 (ja) 2009-05-28 2014-04-09 ノバルティス アーゲー ネプリライシン阻害剤としての置換アミノ酪酸誘導体
SG176009A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
US8519134B2 (en) 2009-11-17 2013-08-27 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
ES2472446T3 (es) 2009-11-30 2014-07-01 Novartis Ag Derivados de imidazol como inhibidores de aldosterona sintasa
EP2364977A1 (en) 2010-01-26 2011-09-14 Reuter Chemische Apparatebau KG Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
CN102267959B (zh) * 2011-07-06 2013-05-01 海南锦瑞制药股份有限公司 一种瑞格列奈晶体、其制备方法及含有该晶体的固体口服制剂
CN103012319B (zh) * 2011-09-20 2015-06-10 浙江九洲药业股份有限公司 瑞格列奈中间体的合成工艺改进
CN102584743A (zh) * 2011-12-28 2012-07-18 中国药科大学 对二甲氨基吡啶瑞格列奈共晶
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
TR201808541T4 (tr) 2013-02-14 2018-07-23 Novartis Ag Nep (nötr endopeptidaz) inhibitörleri olarak ikame edilmiş bisfenil butanoik fosfonik asit türevleri.
KR20160031551A (ko) 2013-07-25 2016-03-22 노파르티스 아게 심부전의 치료를 위한 시클릭 폴리펩티드
HK1218252A1 (zh) 2013-07-25 2017-02-10 Novartis Ag 合成apelin多肽之生物结合物
US10034871B2 (en) 2014-11-07 2018-07-31 Regents Of The University Of Minnesota Salts and compositions useful for treating disease
MA41580A (fr) 2015-01-23 2017-11-29 Novartis Ag Conjugués d'acides gras de l'apeline synthétique présentant une demi-vie améliorée
WO2018034627A1 (en) 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347565A1 (de) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HK1011968A1 (en) 1999-07-23
NO303687B1 (no) 1998-08-17
FI935724L (fi) 1993-12-20
RO113462B1 (ro) 1998-07-30
SK128093A3 (en) 1994-11-09
GR3031654T3 (en) 2000-02-29
DE10075006I2 (de) 2004-01-08
WO1993000337A1 (de) 1993-01-07
JP2921982B2 (ja) 1999-07-19
AU8078191A (en) 1993-01-25
PL170210B1 (pl) 1996-11-29
DE10075006I1 (de) 2000-04-20
EP0589874A1 (de) 1994-04-06
CA2111851C (en) 2002-02-26
CA2111851A1 (en) 1993-01-07
DE59109151D1 (de) 1999-10-14
FI935724A0 (fi) 1993-12-20
CN1068820A (zh) 1993-02-10
AU660930B2 (en) 1995-07-13
NO934726L (no) 1993-12-20
EP0589874B1 (de) 1999-09-08
UY25923A1 (es) 2001-08-27
SK281246B6 (sk) 2001-01-18
FI106027B (fi) 2000-11-15
KR100496720B1 (ko) 2006-01-27
NO934726D0 (no) 1993-12-20
SG43036A1 (en) 1997-10-17
BG98300A (bg) 1994-09-30
DK0589874T3 (da) 2000-04-03
DK0965591T3 (da) 2002-11-18
NO1999017I1 (no) 1999-07-20
CN1048722C (zh) 2000-01-26
JPH06508816A (ja) 1994-10-06

Similar Documents

Publication Publication Date Title
BG61690B1 (bg) (s)(+)-2-етокси-4-/n-/i-(2-пиперидино-фенил)-3-метил-i-бутил/аминокарбонилметил/-бензоена киселина
GB2286395A (en) Pharmaceutical piperazines
WO2001070731A1 (en) Decahydro-isoquinolines
HUT61727A (en) Process for producing 1-(2-arylethyl)-pyrrolidines and pharmaceutical compositions comprising same
JP4842963B2 (ja) 糖尿病を処置するｄｐｐ−ｉｖ阻害剤としての置換ベンゾキノリジン
AU673226B2 (en) Benzoxazine derivatives, their preparation, and their application in therapy
AU2006224853B2 (en) Trifluoromethylbenzamide derivatives and therapeutic uses thereof
MXPA02001599A (es) Derivados de bencimidazol sustituidos con aminocarbonilo, procedimiento para su preparacion su utilizacion como medicamentos.
RU2222535C2 (ru) 3-тетрагидропиридин-4-илиндолы для лечения психотических нарушений
NZ286340A (en) Amides of 2-(4-indolyl piperazia-1-yl)-1-ph-enyl (and bemzyl)ethyl amine derivatives with various (cyclo) alkane carboxylic acids; pharmaceutical compositions
CA1133483A (en) Hexahydro-trans-pyridoindole neuroleptic agents
AU2019227332A1 (en) Crystal form of oxopicolinamide derivative and preparation method therefor
HRP940769A2 (en) (s)(+)-2-ethoxy-4-(n-(1-(2-piperidinophenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)benzoic acid, medicines containing them, that compound and processes for the preparation thereof
SI9111136A (en) (S)-(+)-2-ethoxy-4-/N-/1-(2-piperidino-phenyl)-3-methyl-1-butyl/ aminocarbonylmethyl/-benzoic acid, pharmaceuticals containing this compaund and processes for their preparation
IE990936L (en) Benzoic Acid Derivative
EP0965591A1 (de) (S)-3-Methyl-1-(2-piperidino-phenyl)-1-butylamin, dessen Salze, Herstellung und Verwendung bei der Langzeittherapie des Diabetes mellitus
CN108329282B (zh) 一种苯基哌嗪类衍生物及其制备方法和应用
FI68830B (fi) Dl- eller d-trans-8-fluor-5-(p-fluorfenyl)-2,3,4,4a,5,9b-heksahydro-1h-pyrido(4,3-b)indol som anvaends som mellanprodukt vid framstaellning av terapeutiskt anvaendbara 2-substituerade dl- och d-trans-8-fluor-5-(p-fluorfenyl)-2,3,4,4a,5,9b-heksahydro-1h-pyrido(4,3-b)indoler
HU211240A9 (hu) Hipoglikémiás hatással rendelkező (S)-(+)-2-etoxi-4-[{N-1-(2-piperidino-fenil)-3-metil-butil]-karbamoil}-metil·]- benzoesav vagy hidrátja vagy gyógyszerészetileg elfogadható sója Az átmeneti oltalom az igénypontra vonatkozik.
CZ280430B6 (cs) Kyselina (S)(+)-2-ethoxy-4-/N-/1-(2-piperidinofenyl)-3-methyl-1-butyl/aminokarbonylmethyl/benzoová, farmaceutické prostředky s jejím obsahem, její použití a meziprodukty pro její výrobu
HU215921B (hu) Eljárás (S)-(+)-2-etoxi-4-[{N-/1-(2-piperidino-fenil)-3-metil-butil/-karbamoil}-metil]-benzoesav és ezt tartalmazó gyógyszerkészítmények előállítására
IE85730B1 (en) Benzoic acid derivative
JP2006504675A (ja) アリールカルバメートから誘導される化合物、製造法及び使用
EP2396334A1 (fr) Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique